New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 11, 2012
19:56 EDTHZNPHorizon presents data showing effectiveness of RAYOS
Horizon Pharma announced an additional analysis of data from the pivotal Circadian Administration of Prednisone in Rheumatoid Arthritis-2, CAPRA-2, clinical trial demonstrating that patients with active rheumatoid arthritis (RA) treated with its recently approved RAYOS 5 mg (prednisone) delayed-release tablets had a significant improvement in reduction of fatigue, as determined by the Functional Assessment of Chronic Illness Therapy - Fatigue, FACIT-F, questionnaire. Data were presented during the American College of Rheumatology, ACR/Association of Rheumatology Health Professionals,ARHP, Annual Scientific Meeting in Washington, D.
News For HZNP From The Last 14 Days
Check below for free stories on HZNP the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 28, 2014
06:22 EDTHZNPHorizon Pharma said Duexis, Vimovo to be placed on CVS, Express exlclusion lists
Subscribe for More Information
July 16, 2014
11:28 EDTHZNPHorizon Pharma management to meet with Jefferies
Meetings to be held in San Diego/San Francisco July 23-24 hosted by Jefferies.
July 14, 2014
10:16 EDTHZNPHorizon Pharma management to meet with JMP Securities
Meeting to be held in the Mid-Atlantic area on July 17 hosted by JMP Securities.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use